These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 3114300

  • 1. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature.
    Ghigo E, Mazza E, Imperiale E, Rizzi G, Benso L, Müller EE, Camanni F, Massara F.
    J Clin Endocrinol Metab; 1987 Sep; 65(3):452-6. PubMed ID: 3114300
    [Abstract] [Full Text] [Related]

  • 2. Hexarelin-induced growth hormone response in short stature. Comparison with growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen.
    Guzzaloni G, Grugni G, Morabito F.
    J Endocrinol Invest; 1999 May; 22(5):360-8. PubMed ID: 10401710
    [Abstract] [Full Text] [Related]

  • 3. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E, Imperiale E, Boffano GM, Mazza E, Bellone J, Arvat E, Procopio M, Goffi S, Barreca A, Chiabotto P.
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [Abstract] [Full Text] [Related]

  • 4. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
    [Abstract] [Full Text] [Related]

  • 5. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on the dose-response relationships of growth hormone (GH)-releasing hormone-induced GH secretion in normal subjects.
    Peñalva A, Muruais C, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1990 Feb; 70(2):324-7. PubMed ID: 2105328
    [Abstract] [Full Text] [Related]

  • 6. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?
    Peñalva A, Burguera B, Casabiell X, Tresguerres JA, Dieguez C, Casanueva FF.
    Neuroendocrinology; 1989 May; 49(5):551-4. PubMed ID: 2566942
    [Abstract] [Full Text] [Related]

  • 7. Comparison of growth hormone-releasing effect of growth hormone-releasing hormone, clonidine and pyridostigmine in normal children and adolescents. GH-releasing effect of GHRH, clonidine and pyridostigmine.
    Ghigo E, Arvat E, Nicolosi M, Mazza E, Camanni F.
    Panminerva Med; 1990 May; 32(1):1-3. PubMed ID: 2263395
    [Abstract] [Full Text] [Related]

  • 8. Effect of cholinergic enhancement by pyridostigmine on growth hormone secretion in obese adults and children.
    Ghigo E, Mazza E, Corrias A, Imperiale E, Goffi S, Arvat E, Bellone J, De Sanctis C, Müller EE, Camanni F.
    Metabolism; 1989 Jul; 38(7):631-3. PubMed ID: 2500577
    [Abstract] [Full Text] [Related]

  • 9. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
    Peñalva A, Carballo A, Pombo M, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of the potentiating effect of pyridostigmine, arginine and propranolol on the GHRH-induced GH release in short children.
    Bellone J, Ghigo E, Procopio M, Arvat E, Valente F, Boffano GM, Maccario M, Dentelli P, Camanni F.
    Panminerva Med; 1993 Mar; 35(1):1-4. PubMed ID: 8316397
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone.
    Giusti M, Marini G, Sessarego P, Peluffo F, Valenti S, Caratti C, Giordano G.
    Recenti Prog Med; 1991 Dec; 82(12):665-8. PubMed ID: 1815302
    [Abstract] [Full Text] [Related]

  • 13. Evidence for involvement of endogenous somatostatin in the galanin-induced growth hormone secretion in children.
    Loche S, Vista N, Ghigo E, Vannelli S, Arvat E, Benso L, Corda R, Cella SG, Müller EE, Pintor C.
    Pediatr Res; 1990 Apr; 27(4 Pt 1):405-7. PubMed ID: 1692988
    [Abstract] [Full Text] [Related]

  • 14. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M, Guyda H, Van Vliet G, Tannenbaum GS.
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [Abstract] [Full Text] [Related]

  • 15. Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine.
    Ghigo E, Bellone J, Mazza E, Imperiale E, Procopio M, Valente F, Lala R, De Sanctis C, Camanni F.
    Clin Endocrinol (Oxf); 1990 Jun; 32(6):763-7. PubMed ID: 1974484
    [Abstract] [Full Text] [Related]

  • 16. Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women.
    Arvat E, Cappa M, Casanueva FF, Dieguez C, Ghigo E, Nicolosi M, Valcavi R, Zini M.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):374-7. PubMed ID: 8432781
    [Abstract] [Full Text] [Related]

  • 17. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
    Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Camanni F.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3323-7. PubMed ID: 8784091
    [Abstract] [Full Text] [Related]

  • 18. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J, Diaz MJ, Tresguerres JA, Arce V, Lima L.
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [Abstract] [Full Text] [Related]

  • 19. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
    Cordido F, Peñalva A, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389
    [Abstract] [Full Text] [Related]

  • 20. Cholinergic enhancement of pyridostigmine potentiates spontaneous diurnal but not nocturnal growth hormone secretion in short children.
    Ghigo E, Imperiale E, Mazza E, Goffi S, Procopio M, Müller EE, Camanni F.
    Neuroendocrinology; 1989 Feb; 49(2):134-7. PubMed ID: 2498754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.